207 related articles for article (PubMed ID: 12820780)
21. Are inflammatory cytokines the common link between cancer-associated cachexia and depression?
Illman J; Corringham R; Robinson D; Davis HM; Rossi JF; Cella D; Trikha M
J Support Oncol; 2005; 3(1):37-50. PubMed ID: 15724944
[TBL] [Abstract][Full Text] [Related]
22. Medroxyprogesterone acetate in the management of cancer cachexia.
Madeddu C; Macciò A; Panzone F; Tanca FM; Mantovani G
Expert Opin Pharmacother; 2009 Jun; 10(8):1359-66. PubMed ID: 19445562
[TBL] [Abstract][Full Text] [Related]
23. Neural control of the anorexia-cachexia syndrome.
Laviano A; Inui A; Marks DL; Meguid MM; Pichard C; Rossi Fanelli F; Seelaender M
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1000-8. PubMed ID: 18713954
[TBL] [Abstract][Full Text] [Related]
24. Cancer anorexia-cachexia syndrome: current issues in research and management.
Inui A
CA Cancer J Clin; 2002; 52(2):72-91. PubMed ID: 11929007
[TBL] [Abstract][Full Text] [Related]
25. [The role of proteasome in pathophysiology of cancer cachexia].
Wcisło G; Korniluk J; Wojtuń S
Pol Merkur Lekarski; 2004; 17 Suppl 1():47-9. PubMed ID: 15603347
[TBL] [Abstract][Full Text] [Related]
26. An update on promising agents for the treatment of cancer cachexia.
Madeddu C; Mantovani G
Curr Opin Support Palliat Care; 2009 Dec; 3(4):258-62. PubMed ID: 19667995
[TBL] [Abstract][Full Text] [Related]
27. Current pharmacological management of anorexia in cancer patients.
Bruera E
Oncology (Williston Park); 1992 Jan; 6(1):125-30; discussion 132, 137. PubMed ID: 1531597
[TBL] [Abstract][Full Text] [Related]
28. The pivotal role of cytokines in muscle wasting during cancer.
Argilés JM; Busquets S; López-Soriano FJ
Int J Biochem Cell Biol; 2005 Oct; 37(10):2036-46. PubMed ID: 16105746
[TBL] [Abstract][Full Text] [Related]
29. Cancer cachexia syndrome in head and neck cancer patients: Part II. Pathophysiology.
George J; Cannon T; Lai V; Richey L; Zanation A; Hayes DN; Shores C; Guttridge D; Couch M
Head Neck; 2007 May; 29(5):497-507. PubMed ID: 17390378
[TBL] [Abstract][Full Text] [Related]
30. Anticancer drugs that induce cancer-associated cachectic syndromes.
Tohgo A; Kumazawa E; Akahane K; Asakawa A; Inui A
Expert Rev Anticancer Ther; 2002 Feb; 2(1):121-9. PubMed ID: 12113061
[TBL] [Abstract][Full Text] [Related]
31. Melanocortin interventions in cachexia: how soon from bench to bedside?
DeBoer MD
Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):457-62. PubMed ID: 17563464
[TBL] [Abstract][Full Text] [Related]
32. Novel approaches to the treatment of cachexia.
Argilés JM; López-Soriano FJ; Busquets S
Drug Discov Today; 2008 Jan; 13(1-2):73-8. PubMed ID: 18190867
[TBL] [Abstract][Full Text] [Related]
33. Central mechanisms controlling appetite and food intake in a cancer setting: an update.
Fletcher AL; Marks DL
Curr Opin Support Palliat Care; 2007 Dec; 1(4):306-11. PubMed ID: 18685380
[TBL] [Abstract][Full Text] [Related]
34. Cachexia, survival and the acute phase response.
Stephens NA; Skipworth RJ; Fearon KC
Curr Opin Support Palliat Care; 2008 Dec; 2(4):267-74. PubMed ID: 19060563
[TBL] [Abstract][Full Text] [Related]
35. Anorexia/cachexia-related quality of life for children with cancer.
Lai JS; Cella D; Peterman A; Barocas J; Goldman S
Cancer; 2005 Oct; 104(7):1531-9. PubMed ID: 16088963
[TBL] [Abstract][Full Text] [Related]
36. Metabolic responses to tumour disease and progression: tumour-host interaction.
Cravo ML; Glória LM; Claro I
Clin Nutr; 2000 Dec; 19(6):459-65. PubMed ID: 11104599
[TBL] [Abstract][Full Text] [Related]
37. Mediators involved in the cancer anorexia-cachexia syndrome: past, present, and future.
Argilés JM; Busquets S; García-Martínez C; López-Soriano FJ
Nutrition; 2005 Sep; 21(9):977-85. PubMed ID: 16043325
[TBL] [Abstract][Full Text] [Related]
38. Clinical impact of cachexia on survival and outcome of cancer patients.
Dimitriu C; Martignoni ME; Bachmann J; Fröhlich B; Tintărescu G; Buliga T; Lică I; Constantinescu G; Beuran M; Friess H
Rom J Intern Med; 2005; 43(3-4):173-85. PubMed ID: 16812978
[TBL] [Abstract][Full Text] [Related]
39. Cancer cachexia and targeting chronic inflammation: a unified approach to cancer treatment and palliative/supportive care.
MacDonald N
J Support Oncol; 2007 Apr; 5(4):157-62; discussion 164-6, 183. PubMed ID: 17500503
[TBL] [Abstract][Full Text] [Related]
40. Dietary and pharmacological management of severe catabolic conditions.
Elamin E
Am J Med Sci; 2011 Dec; 342(6):513-8. PubMed ID: 21709539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
